Skip to main content
Top

17-06-2024 | Pathology | Original Article

Multimodal integration of radiology and pathology signatures for distinguishing between aldosterone-producing adenomas and nonfunctional adrenal adenomas

Authors: Zeyu Piao, Tingting Liu, Huijie Yang, Mingzhu Meng, Haifeng Shi, Shenglin Gao, Tongqing Xue, Zhongzhi Jia

Published in: Endocrine

Login to get access

Abstract

Objective

To develop and validate a nomogram combining radiomics and pathology features to distinguish between aldosterone-producing adenomas (APAs) and nonfunctional adrenal adenomas (NF-AAs).

Methods

Consecutive patients diagnosed with adrenal adenomas via computed tomography (CT) or pathologic analysis between January 2011 and November 2022 were eligible for inclusion in this retrospective study. CT images and hematoxylin & eosin–stained slides were used for annotation and feature extraction. The selected radiomics and pathology features were used to develop a risk model using various machine learning models, and the area under the receiver operating characteristic curve (AUC) was determined to evaluate diagnostic performance. The predicted results from radiomics and pathology features were combined and visualized using a nomogram.

Results

A total of 211 patients (APAs, n = 59; NF-AAs, n = 152) were included in this study, with patients randomly divided into either the training set or the testing set at a ratio of 8:2. The ExtraTrees model yielded a sensitivity of 0.818, a specificity of 0.733, and an accuracy of 0.756 (AUC = 0.817; 95% confidence interval [CI]: 0.675–0.958) in the radiomics testing set and a sensitivity of 0.999, a specificity of 0.842, and an accuracy of 0.867 (AUC = 0.905, 95% CI: 0.792–1.000) in the pathology testing set. A nomogram combining radiomics and pathology features demonstrated a strong performance (AUC = 0.912; 95% CI: 0.807–1.000).

Conclusion

A nomogram combining radiomics and pathology features demonstrated strong predictive accuracy and discrimination capability. This model may help clinicians to distinguish between APAs and NF-AAs.
Appendix
Available only for authorised users
Literature
1.
go back to reference M. Arruda, E. Mello Ribeiro Cavalari, M. Pessoa De Paula et al. The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test. J. Hum. Hypertens. 32(1), 3–11 (2017)CrossRefPubMed M. Arruda, E. Mello Ribeiro Cavalari, M. Pessoa De Paula et al. The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test. J. Hum. Hypertens. 32(1), 3–11 (2017)CrossRefPubMed
2.
go back to reference Y.S. Elhassan, F. Alahdab, A. Prete et al. Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis. Ann. Intern Med 171(2), 107–116 (2019)CrossRefPubMed Y.S. Elhassan, F. Alahdab, A. Prete et al. Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis. Ann. Intern Med 171(2), 107–116 (2019)CrossRefPubMed
3.
go back to reference D. Lopez, M.A. Luque-Fernandez, A. Steele et al. Nonfunctional” adrenal tumors and the risk for incident diabetes and cardiovascular outcomes: A cohort study. Ann. Intern Med 165(8), 533–542 (2016)CrossRefPubMedPubMedCentral D. Lopez, M.A. Luque-Fernandez, A. Steele et al. Nonfunctional” adrenal tumors and the risk for incident diabetes and cardiovascular outcomes: A cohort study. Ann. Intern Med 165(8), 533–542 (2016)CrossRefPubMedPubMedCentral
4.
go back to reference M.M. Tuna, N.N. Imga, B.A. Doğan et al. Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis. J. Endocrinol. Invest 37(8), 765–768 (2014)CrossRefPubMed M.M. Tuna, N.N. Imga, B.A. Doğan et al. Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis. J. Endocrinol. Invest 37(8), 765–768 (2014)CrossRefPubMed
5.
go back to reference M.G. Elbanan, S. Javadi, D. Ganeshan et al. Adrenal cortical adenoma: current update, imaging features, atypical findings, and mimics. Abdom. Radio (NY) 45(4), 905–916 (2020)CrossRef M.G. Elbanan, S. Javadi, D. Ganeshan et al. Adrenal cortical adenoma: current update, imaging features, atypical findings, and mimics. Abdom. Radio (NY) 45(4), 905–916 (2020)CrossRef
6.
go back to reference F. Ceccato, M. Barbot, C. Scaroni et al. Frequently asked questions and answers (if any) in patients with adrenal incidentaloma. J. Endocrinol. Invest 44(12), 2749–2763 (2021)CrossRefPubMedPubMedCentral F. Ceccato, M. Barbot, C. Scaroni et al. Frequently asked questions and answers (if any) in patients with adrenal incidentaloma. J. Endocrinol. Invest 44(12), 2749–2763 (2021)CrossRefPubMedPubMedCentral
7.
go back to reference M. Araujo-Castro, M. Paja Fano, M. González Boillos et al. Adrenal venous sampling in primary aldosteronism: Experience of a Spanish multicentric study (Results from the SPAIN-ALDO Register)[J]. Endocrine 78(2), 363–372 (2022)CrossRefPubMed M. Araujo-Castro, M. Paja Fano, M. González Boillos et al. Adrenal venous sampling in primary aldosteronism: Experience of a Spanish multicentric study (Results from the SPAIN-ALDO Register)[J]. Endocrine 78(2), 363–372 (2022)CrossRefPubMed
8.
go back to reference M. Fassnacht, W. Arlt, I. Bancos et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 175(2), G1–g34 (2016)CrossRefPubMed M. Fassnacht, W. Arlt, I. Bancos et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 175(2), G1–g34 (2016)CrossRefPubMed
9.
go back to reference S. Ishidoya, A. Ito, K. Sakai et al. Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J. Urol. 174(1), 40–3 (2005)CrossRefPubMed S. Ishidoya, A. Ito, K. Sakai et al. Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J. Urol. 174(1), 40–3 (2005)CrossRefPubMed
10.
go back to reference K.M. Boehm, E.A. Aherne, L. Ellenson et al. Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer[J]. Nat. Cancer 3(6), 723–733 (2022)CrossRefPubMedPubMedCentral K.M. Boehm, E.A. Aherne, L. Ellenson et al. Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer[J]. Nat. Cancer 3(6), 723–733 (2022)CrossRefPubMedPubMedCentral
11.
go back to reference R. Cao, F. Yang, S.C. Ma et al. Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer[J]. Theranostics 10(24), 11080–11091 (2020)CrossRefPubMedPubMedCentral R. Cao, F. Yang, S.C. Ma et al. Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer[J]. Theranostics 10(24), 11080–11091 (2020)CrossRefPubMedPubMedCentral
12.
go back to reference L. Feng, Z. Liu, C. Li et al. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study. Lancet Digit Health 4(1), e8–e17 (2022)CrossRefPubMed L. Feng, Z. Liu, C. Li et al. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study. Lancet Digit Health 4(1), e8–e17 (2022)CrossRefPubMed
13.
go back to reference R.S. Vanguri, J. Luo, A.T. Aukerman et al. Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer. Nat. Cancer 3(10), 1151–1164 (2022)CrossRefPubMedPubMedCentral R.S. Vanguri, J. Luo, A.T. Aukerman et al. Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer. Nat. Cancer 3(10), 1151–1164 (2022)CrossRefPubMedPubMedCentral
14.
go back to reference X. Wang, K. Li, H. Sun et al. Differentiation between adrenal adenomas and nonadenomas using dynamic contrast-enhanced computed tomography. Onco Targets Ther. 9, 6809–6817 (2016)CrossRefPubMedPubMedCentral X. Wang, K. Li, H. Sun et al. Differentiation between adrenal adenomas and nonadenomas using dynamic contrast-enhanced computed tomography. Onco Targets Ther. 9, 6809–6817 (2016)CrossRefPubMedPubMedCentral
15.
go back to reference T.A. Williams, J.W.M. Lenders, P. Mulatero et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diab Endocrinol. 5(9), 689–699 (2017)CrossRef T.A. Williams, J.W.M. Lenders, P. Mulatero et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diab Endocrinol. 5(9), 689–699 (2017)CrossRef
16.
go back to reference Y. Song, J. Yang, H. Shen et al. Development and validation of model for sparing adrenal venous sampling in diagnosing unilateral primary aldosteronism. J. Hypertens. 40(9), 1692–1701 (2022)CrossRefPubMed Y. Song, J. Yang, H. Shen et al. Development and validation of model for sparing adrenal venous sampling in diagnosing unilateral primary aldosteronism. J. Hypertens. 40(9), 1692–1701 (2022)CrossRefPubMed
17.
go back to reference H. Wang, F. Wang, Y. Zhang et al. Surgical outcomes of aldosterone-producing adenoma on the basis of the histopathological findings. Front Endocrinol. (Lausanne) 12, 663096 (2021)CrossRefPubMed H. Wang, F. Wang, Y. Zhang et al. Surgical outcomes of aldosterone-producing adenoma on the basis of the histopathological findings. Front Endocrinol. (Lausanne) 12, 663096 (2021)CrossRefPubMed
18.
go back to reference T. Chen, C. Guestrin, Xgboost: A scalable tree boosting system[C]. Proceedings of the 22nd acm sigkdd international conference on knowledge discovery and data mining. 785–794 (2016) T. Chen, C. Guestrin, Xgboost: A scalable tree boosting system[C]. Proceedings of the 22nd acm sigkdd international conference on knowledge discovery and data mining. 785–794 (2016)
19.
go back to reference P.Y. Hao, J.H. Chiang, Y.D. Chen, Possibilistic classification by support vector networks. Neural Netw. 149, 40–56 (2022)CrossRefPubMed P.Y. Hao, J.H. Chiang, Y.D. Chen, Possibilistic classification by support vector networks. Neural Netw. 149, 40–56 (2022)CrossRefPubMed
20.
go back to reference G. Ke, Q. Meng, T. Finley et al. Lightgbm: A highly efficient gradient boosting decision tree. 31st Conference on Neural Information Processing Systems (NIPS, Long Beach, CA, USA, 2017) G. Ke, Q. Meng, T. Finley et al. Lightgbm: A highly efficient gradient boosting decision tree. 31st Conference on Neural Information Processing Systems (NIPS, Long Beach, CA, USA, 2017)
21.
23.
go back to reference R.J. Gillies, P.E. Kinahan, H. Hricak, Radiomics: Images are more than pictures, they are data. Radiology 278(2), 563–77 (2016)CrossRefPubMed R.J. Gillies, P.E. Kinahan, H. Hricak, Radiomics: Images are more than pictures, they are data. Radiology 278(2), 563–77 (2016)CrossRefPubMed
24.
go back to reference Ba.R. Mendi, M.A. Gülbay, CT radiomics analysis of the adrenal masses: Can we discriminate lipid-poor adenomas from the pheochromocytoma and malignant masses?. Curr. Med Imaging 19(9), 1018–1030 (2023)PubMed Ba.R. Mendi, M.A. Gülbay, CT radiomics analysis of the adrenal masses: Can we discriminate lipid-poor adenomas from the pheochromocytoma and malignant masses?. Curr. Med Imaging 19(9), 1018–1030 (2023)PubMed
25.
go back to reference L. Yip, Q.Y. Duh, H. Wachtel et al. American association of endocrine surgeons guidelines for adrenalectomy: Executive summary. JAMA Surg. 157(10), 870–877 (2022)CrossRefPubMedPubMedCentral L. Yip, Q.Y. Duh, H. Wachtel et al. American association of endocrine surgeons guidelines for adrenalectomy: Executive summary. JAMA Surg. 157(10), 870–877 (2022)CrossRefPubMedPubMedCentral
26.
go back to reference F. Ctvrtlik, P. Koranda, T. Tichy, Adrenal disease: a clinical update and overview of imaging. A review. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czech Repub. 158(1), 23–34 (2014)CrossRefPubMed F. Ctvrtlik, P. Koranda, T. Tichy, Adrenal disease: a clinical update and overview of imaging. A review. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czech Repub. 158(1), 23–34 (2014)CrossRefPubMed
27.
go back to reference M.J. Kempers, J.W. Lenders, L. Van Outheusden et al. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism[J]. Ann. Intern Med 151(5), 329–37 (2009)CrossRefPubMed M.J. Kempers, J.W. Lenders, L. Van Outheusden et al. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism[J]. Ann. Intern Med 151(5), 329–37 (2009)CrossRefPubMed
28.
go back to reference O. Mete, L.A. Erickson, C.C. Juhlin et al. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors[J]. Endocr. Pathol. 33(1), 155–196 (2022)CrossRefPubMedPubMedCentral O. Mete, L.A. Erickson, C.C. Juhlin et al. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors[J]. Endocr. Pathol. 33(1), 155–196 (2022)CrossRefPubMedPubMedCentral
29.
go back to reference H. Gunnarsdottir, B.A. Agnarsson, S. Jonasdottir et al. Immunohistochemical staining seems mandatory for individualizing and shortening follow-up in unilateral primary aldosteronism[J]. Clin. Endocrinol. (Oxf). 99(5), 441–448 (2023). H. Gunnarsdottir, B.A. Agnarsson, S. Jonasdottir et al. Immunohistochemical staining seems mandatory for individualizing and shortening follow-up in unilateral primary aldosteronism[J]. Clin. Endocrinol. (Oxf). 99(5), 441–448 (2023).
31.
go back to reference J.N. Kather, A.T. Pearson, N. Halama et al. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nat. Med. 25(7), 1054–1056 (2019)CrossRefPubMedPubMedCentral J.N. Kather, A.T. Pearson, N. Halama et al. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nat. Med. 25(7), 1054–1056 (2019)CrossRefPubMedPubMedCentral
32.
go back to reference O.J. Skrede, S. De Raedt, A. Kleppe et al. Deep learning for prediction of colorectal cancer outcome: a discovery and validation study. Lancet 395(10221), 350–360 (2020)CrossRefPubMed O.J. Skrede, S. De Raedt, A. Kleppe et al. Deep learning for prediction of colorectal cancer outcome: a discovery and validation study. Lancet 395(10221), 350–360 (2020)CrossRefPubMed
33.
go back to reference P.T. Chen, D. Chang, K.L. Liu et al. Radiomics utilization to differentiate nonfunctional adenoma in essential hypertension and functional adenoma in primary aldosteronism. Sci. Rep. 12(1), 88–92 (2022) P.T. Chen, D. Chang, K.L. Liu et al. Radiomics utilization to differentiate nonfunctional adenoma in essential hypertension and functional adenoma in primary aldosteronism. Sci. Rep. 12(1), 88–92 (2022)
34.
go back to reference T.A. Williams, C.E. Gomez-Sanchez, W.E. Rainey et al. International histopathology consensus for unilateral primary aldosteronism. J. Clin. Endocrinol. Metab. 106(1), 42–54 (2021)CrossRefPubMed T.A. Williams, C.E. Gomez-Sanchez, W.E. Rainey et al. International histopathology consensus for unilateral primary aldosteronism. J. Clin. Endocrinol. Metab. 106(1), 42–54 (2021)CrossRefPubMed
Metadata
Title
Multimodal integration of radiology and pathology signatures for distinguishing between aldosterone-producing adenomas and nonfunctional adrenal adenomas
Authors
Zeyu Piao
Tingting Liu
Huijie Yang
Mingzhu Meng
Haifeng Shi
Shenglin Gao
Tongqing Xue
Zhongzhi Jia
Publication date
17-06-2024
Publisher
Springer US
Published in
Endocrine
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-024-03827-y
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare